WHO ICTRP trial
Role of Maharishi Amrit Kalash, Ayurvedic herbal medicine on Breast Cancer
CTRI/2019/02/017775 · Clinical Trials Registry India (CTRI) · Recruiting
Key facts
| Trial ID | CTRI/2019/02/017775 |
|---|---|
| Public title | Role of Maharishi Amrit Kalash, Ayurvedic herbal medicine on Breast Cancer |
| Scientific title | Study of effectiveness of Maharishi Amrit Kalash on Breast Cancer as adjunct therapy along with Docetaxil and Epirubicine chemotherapy. |
| Primary sponsor | Maharishi Ayurveda Products Pvt Ltd |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India |
| Conditions | Health Condition 1: null- Breast Cancer |
| Interventions | Intervention1: MAK: MAK 4 MAK 5 Intervention2: MAK (MAK 4 and MAK 5): MAK 4 paste dose 2tsf twice a day with milk orally. MAK 5 dose 2tablets twice a day with luke warm water orally for a period of 5 to 6 months Control Intervention1: Not… |
| Registration date | Feb 22, 2019 |
| Target size | 160 |
| Secondary IDs | NIL |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: